These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32447238)

  • 1. Changing characteristics of epilepsy interventional clinical trials over the last decade: Clinicaltrials.Gov registry.
    Eslami V; Lola MC; Karceski SC; Cavazos JE; Szabó CÁ
    Epilepsy Res; 2020 Aug; 164():106350. PubMed ID: 32447238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacosamide add-on therapy for partial epilepsy.
    Weston J; Shukralla A; McKay AJ; Marson AG
    Cochrane Database Syst Rev; 2015 Jun; (6):CD008841. PubMed ID: 26077821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yoga for epilepsy.
    Panebianco M; Sridharan K; Ramaratnam S
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001524. PubMed ID: 28982217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
    Devinsky O; Marsh E; Friedman D; Thiele E; Laux L; Sullivan J; Miller I; Flamini R; Wilfong A; Filloux F; Wong M; Tilton N; Bruno P; Bluvstein J; Hedlund J; Kamens R; Maclean J; Nangia S; Singhal NS; Wilson CA; Patel A; Cilio MR
    Lancet Neurol; 2016 Mar; 15(3):270-8. PubMed ID: 26724101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for ineligibility for clinical trials of patients with medication-resistant epilepsy.
    Kerr WT; Chen H; Figuera Losada M; Cheng C; Liu T; French J
    Epilepsia; 2023 May; 64(5):e56-e60. PubMed ID: 36869635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current and emerging therapeutic approaches in drug-resistant epilepsy management.
    Mehdizadeh A; Barzegar M; Negargar S; Yahyavi A; Raeisi S
    Acta Neurol Belg; 2019 Jun; 119(2):155-162. PubMed ID: 30868468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.
    Löscher W
    Neurochem Res; 2017 Jul; 42(7):1873-1888. PubMed ID: 28290134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
    Krauss GL; Klein P; Brandt C; Lee SK; Milanov I; Milovanovic M; Steinhoff BJ; Kamin M
    Lancet Neurol; 2020 Jan; 19(1):38-48. PubMed ID: 31734103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Marson AG; Weston J; Tudur Smith C
    Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol for Epilepsy: New Hope on the Horizon?
    Sanmartin PE; Detyniecki K
    Clin Ther; 2018 Sep; 40(9):1438-1441. PubMed ID: 30150078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).
    Maguire MJ; Jackson CF; Marson AG; Nolan SJ
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011792. PubMed ID: 27434597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin as add-on treatment for epilepsy.
    Brigo F; Igwe SC; Del Felice A
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD006967. PubMed ID: 27513702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin as add-on treatment for epilepsy.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2016 Mar; 3():CD006967. PubMed ID: 26986179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptic drugs for seizure control in people with neurocysticercosis.
    Sharma M; Singh T; Mathew A
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009027. PubMed ID: 26455722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of chronic drug-refractory focal onset epilepsy: Can it be prevented?
    Ben-Menachem E; Schmitz B; Kälviäinen R; Thomas RH; Klein P
    Epilepsy Behav; 2023 Nov; 148():109435. PubMed ID: 37748414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001909. PubMed ID: 27329345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the low glutamate diet as an adjunct treatment for pediatric epilepsy: A pilot randomized controlled trial.
    Sarlo GL; Kao A; Holton KF
    Seizure; 2023 Mar; 106():138-147. PubMed ID: 36867910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.